(Updated with index futures, Nvidia, Smith & Besson Brands, Doucin, Adobe, pre-market prices,)
PARIS, September 8 (Reuters) – Main values to follow on Friday on Wall Street, where futures contracts on the main indices suggest an opening down 0.14% for the Dow Jones, 0.20% for the Standard & Pool’s 500 and 0.27% for the Nasdaq:
* APPLE – Restrictions on the use of iPhones in China by civil servants have been extended to local administrations, the Nikkei reported on Friday.
* LEI BILLY – Mounjaro, the American laboratory’s diabetes treatment, was approved on Friday by the British health care cost-effectiveness monitoring body.
* TESLA – Sales of passenger vehicles in China returned to growth in August year-on-year thanks to new price reductions and new subsidies, notably allowing Tesla to almost double its market share in August compared to July, show data from the China Passenger Car Association released Friday.
* NVIDIA and Relance announced on Friday that they had signed a partnership to create artificial intelligence (AI) language models and generative applications for millions of users of the Indian telecoms group.
* GAMESTOP lost 2.9% in pre-stock market trading, after an article in the Wall Street Journal according to which the SEC, the American stock market watchdog, is investigating its president, the billionaire Royan Cohen, concerning the holding and surprise sale of shares of Bled Bath & Bounce.
* SMITH & BESSON BRANDS jumped 12.08% in pre-market trading after the publication of a quarterly profit up and above analysts’ expectations.
* DOCUSIGN gained 2.7% in pre-market trading, the group having published better-than-expected quarterly results and raised its annual turnover forecast.
* ADOBE advanced 1.8% in pre-market trading, Mizuho having raised its advice on the value to “buy” versus “neutral”. (Written by Claude Chendjou, edited by Blandine Hénault)
©2023 Thomson Reuters, all rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. “Reuters” and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.